Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Measure Better Investing in Racial Equity Beyond Aid Beyond Trade-offs Impact en las Americas New Revivalists Women Rising in India Operation Impact
Smarter Money Women Rising 2030 Finance Locavesting Inclusive Economy Regeneration Impact Tech New Power Geographies
Slack Conference Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Industry News Impact Management Good Business Personal Finance Faith and investing Billionaires
Gender Lens Investing Women Rising in India
SDGs Climate Finance Clean Energy Innovative Finance Full Stack Capital Long-termism
Opportunity Zones Investing in place
Entrepreneurship Return on Inclusion Good Jobs Inclusive Fintech Creative economy Housing New Schooled Well Being People on the Move
Conservation Finance Farmer Finance Financing Fish
Blockchain/AI/IoT Urban Tech Food Tech Inclusive Fintech
Human Rights Democracy and Peace News and Information
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States Growth Markets
Subscribe
Features
Series
Themes
Community
Data
Subscribe Log In
More

Bill Gates funds biotech accelerator for Alzheimer’s



Gates is backing a $30 million venture philanthropy accelerator that will support early stage biotech companies working on Alzheimer’s research, detection and diagnosis. The Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator will make grants to biotech companies, academic medical centers, nonprofits and others over the next three years.

“Alzheimer’s research is a frontier where we can dramatically improve human life,” Gates wrote on his blog, while outlining a priority of finding simpler, less invasive and more affordable diagnostic tests as a starting point. Estée Lauder chairman Leonard Lauder, the Dolby family, the Charles and Helen Schwab Foundation, and others are also supporting the accelerator.

Gate’s funding for the accelerator is part of a $100 million commitment pledge he made to advancing Alzheimer’s research and eventually finding a cure. (For Gates, supporting Alzheimer’s research is personal: his father was diagnosed with the disease.) His commitment to the Diagnostics Accelerator follows his pledge of $50 million the U.K.-based Dementia Discovery Fund.

You might also like...